Status:
WITHDRAWN
Prediction of NEC With Urinary iFABP
Lead Sponsor:
Loma Linda University
Conditions:
Prematurity
Necrotizing Enterocolitis
Eligibility:
All Genders
Up to 2 years
Phase:
PHASE2
Brief Summary
During the first four days of life, intestinal fatty acid binding protein (iFABP) is elevated in the urine of premature babies who go on to develop necrotizing enterocolitis (NEC) days to weeks later....
Detailed Description
Necrotizing enterocolits (NEC) occurs with an incidence of 3-7% in very low birth weight (\<1500g) infants and is associated with significant morbidity and mortality. Earlier detection of a subclinica...
Eligibility Criteria
Inclusion
- Gestational age less than 33 weeks
- Admission to Loma Linda University Children's Hospital NICU within 48 hours of life
Exclusion
- Anuria
- Congenital gastrointestinal anomaly
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01805206
Start Date
November 1 2014
End Date
July 1 2016
Last Update
May 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Children's Hospital
Loma Linda, California, United States, 92354